Balaji Narasimhan

4.5k citations
106 papers · 3.5k indexed · 1 hit paper · h-index 31
Topics
Immunotherapy and Immune Responses (17 papers)Advanced Drug Delivery Systems (14 papers)Protein purification and stability (10 papers)
Partner nations
United StatesItalyCanada

In The Last Decade

Balaji Narasimhan

102 papers receiving 3.5k citations

Hit Papers

Mathematical models in drug delivery: How modeling has sh...20142026201820222014100200300400

Peers

Balaji Narasimhan
Comparison fields: 5 of 150
  • Molecular Biology 1.1k
  • Pharmaceutical Science 814
  • Biomaterials 810
  • Immunology 620
  • Biomedical Engineering 570
Replace Balaji Narasimhan with:
Balaji Narasimhan United States
Yun‐Jaie Choi South Korea
Jie Wu China
Alexandra Correia Finland
Elke Walter Switzerland
Amulya K. Panda India
S.S. Davis United Kingdom
Fakhrul Ahsan United States
Alejandro Sánchez Spain
António J. Almeida Portugal
Balaji Narasimhan relative to Balaji Narasimhan United States Balaji Narasimhan's profile →
Citations per field
00.5×1.5×
Balaji Narasimhan · 1×
Citations per year

Countries citing papers authored by Balaji Narasimhan

Since Specialization
Citations

This map shows the geographic impact of Balaji Narasimhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Balaji Narasimhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Balaji Narasimhan more than expected).

Fields of papers citing papers by Balaji Narasimhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Balaji Narasimhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Balaji Narasimhan. The network helps show where Balaji Narasimhan may publish in the future.

Co-authorship network of co-authors of Balaji Narasimhan

This figure shows the co-authorship network connecting the top 25 collaborators of Balaji Narasimhan. A scholar is included among the top collaborators of Balaji Narasimhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Balaji Narasimhan. Balaji Narasimhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 4
5 2
6 4
7 8
8 5
9 28
10 17
11 13
12 31
13 86
14 47
15 63
16 56
17 16
18
Verwey transition and magnetic irreversibility in nano-crystalline magnetite produced by magnetotactic bacteria
2
19 108
20 17

About Balaji Narasimhan

Balaji Narasimhan is a scholar working on Pharmaceutical Science, Biomaterials and Microbiology, having authored 106 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (17 papers), Advanced Drug Delivery Systems (14 papers) and Protein purification and stability (10 papers). The work is most often cited by research in Pharmaceutical Science (814 citations), Biomaterials (810 citations) and Molecular Medicine (252 citations). Balaji Narasimhan has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Nicholas A. Peppas, Surya K. Mallapragada, Nikolaos A. Peppas, Michael J. Wannemuehler, Matt J. Kipper, Latrisha K. Petersen, Amy S. Determan, Jia Feng, Elizabeth Shen and Róbert Langer. Their work appears in journals such as The Journal of Immunology, Biomaterials and Macromolecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026